Home Cardiovascular Diseases
Cell Star

Cardiovascular Diseases

Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels. They include conditions such as coronary artery disease, heart failure, arrhythmias, cardiomyopathy, and cerebrovascular diseases like stroke. CVDs are the leading cause of death globally, accounting for nearly 18 million deaths each year. They result primarily from atherosclerosis, a condition in which fatty deposits build up in the walls of arteries, leading to reduced blood flow and potential blockages.

While lifestyle changes and pharmacological treatments have significantly improved outcomes, supportive and emerging therapies like stem cell therapy and hyperbaric oxygen therapy (HBOT) are offering promising new avenues for cardiovascular repair and management.

Types of Cardiovascular Diseases

  • Coronary Artery Disease (CAD): Blockage of the arteries supplying the heart, leading to angina or heart attacks.
  • Cerebrovascular Disease: Affects blood flow to the brain, causing strokes or transient ischemic attacks (TIAs).
  • Peripheral Arterial Disease (PAD): Narrowing of arteries supplying limbs.
  • Heart Failure: The heart’s inability to pump blood effectively.
  • Arrhythmias: Irregular heartbeats, such as atrial fibrillation or ventricular tachycardia.
  • Congenital Heart Disease: Structural abnormalities present at birth.
  • Cardiomyopathies: Disease of the heart muscle that impairs function.

Causes and Risk Factors

CVDs are typically caused by a combination of modifiable and non-modifiable factors:

Modifiable risk factors:

  • Hypertension
  • High cholesterol
  • Smoking
  • Obesity
  • Diabetes
  • Physical inactivity
  • Poor diet
  • Excessive alcohol intake
  • Stress

Non-modifiable risk factors:

  • Age
  • Gender (men are at higher risk earlier in life)
  • Family history
  • Ethnicity

Pathophysiology

The primary mechanism in most CVDs is atherosclerosis, which involves:

  • Endothelial dysfunction
  • Lipid accumulation in arterial walls
  • Inflammatory responses and plaque formation
  • Plaque rupture and thrombosis, leading to acute events like myocardial infarction or stroke

In heart failure, the heart’s pumping efficiency is compromised due to conditions like myocardial infarction, hypertension, or cardiomyopathy.

Symptoms

Symptoms vary depending on the specific type of CVD but may include:

  • Chest pain or discomfort (angina)
  • Shortness of breath
  •  Palpitations
  • Fatigue or weakness
  • Swelling in legs and ankles (edema)
  • Dizziness or fainting
  • Sudden numbness or weakness (in stroke)

Diagnosis

Diagnosis involves a thorough history, physical exam, and diagnostic testing:

  • Electrocardiogram (ECG)
  • Echocardiography
  • Stress testing
  • Cardiac biomarkers (e.g., troponin)
  • Coronary angiography
  • CT/MRI scans
  • Blood tests: Lipid profile, glucose, inflammatory markers

Conventional Treatment

Treatment strategies depend on the specific CVD and its severity:

Lifestyle modifications:

  • Smoking cessation
  • Regular exercise
  • Heart-healthy diet (low salt, low saturated fat)
  • Weight management

Medications:

  • Antihypertensives (ACE inhibitors, beta-blockers, diuretics)
  • Statins (cholesterol-lowering drugs)
  • Antiplatelet agents (aspirin, clopidogrel)
  • Anticoagulants
  • Nitrates for angina
  • Anti-arrhythmic drugs

Interventional procedures:

  • Percutaneous coronary intervention (angioplasty with stents)
  • Coronary artery bypass grafting (CABG)
  • Pacemaker or defibrillator implantation

Cardiac rehabilitation: Structured programs involving education, exercise training, and counseling

Stem Cell Therapy in Cardiovascular Diseases

Stem cell therapy is being explored for repairing damaged cardiac tissue and restoring function, especially after heart attacks or in heart failure.

Types of stem cells:

  • Bone marrow-derived stem cells
  • Mesenchymal stem cells (MSCs)
  • Cardiac progenitor cells

Mechanisms of action:

  • Differentiation into cardiomyocytes and vascular cells
  • Release of paracrine factors promoting angiogenesis and cell survival
  • Reduction of fibrosis and inflammation

Clinical applications:

  • Post-myocardial infarction regeneration
  • Chronic heart failure
  • Revascularization in peripheral artery disease

Clinical trials:

  • Trials like SCIPIO, BAMI, and CHART-1 show encouraging but mixed results
  • Challenges remain with cell survival, delivery, and integration

Hyperbaric Oxygen Therapy (HBOT) in Cardiovascular Diseases

HBOT involves breathing 100% oxygen in a pressurized chamber, enhancing oxygen delivery to hypoxic tissues.

Mechanism:

  • Increases plasma oxygen concentration
  • Promotes angiogenesis
  • Reduces ischemia and oxidative stress
  • Improves mitochondrial function

Applications:

  • Treatment of ischemic wounds in peripheral arterial disease
  • Recovery after myocardial infarction
  • Adjunct for chronic refractory angina
  • Stroke rehabilitation support

Evidence:

  • Some studies show improved left ventricular function and reduced inflammation
  • Still under investigation for

Supportive Care and Prevention

Supportive care involves risk factor management and long-term follow-up:

  • Regular monitoring: Blood pressure, cholesterol, glucose
  • Nutritional counseling: DASH or Mediterranean diet
  • Physical activity: 150 minutes of moderate aerobic exercise per week
  • Stress reduction: Meditation, yoga, or therapy
  • Smoking and alcohol: Complete cessation of tobacco, limited alcohol

Technology and Innovation

  • Wearables and heart monitors: Help track rhythm, rate, and physical activity
  • Remote monitoring: For heart failure patients to track fluid retention
  • Artificial intelligence: Aids in imaging interpretation and risk prediction

Prognosis

Prognosis depends on the specific condition and early management. With appropriate lifestyle changes, medications, and regular follow-up, many individuals live long and active lives. Advanced therapies like stem cell therapy and HBOT are offering hope for better regeneration and recovery.

Conclusion

Cardiovascular diseases remain a leading global health burden but are largely preventable and manageable with timely intervention. Conventional treatment, when combined with lifestyle changes and emerging therapies like stem cell therapy and HBOT, can significantly improve patient outcomes. A comprehensive, personalized approach that includes preventive care, medical treatment, rehabilitation, and supportive therapies is essential to combat the impact of CVD and enhance long-term heart health.

Working Time
  • Monday-Saturday 09:00 AM  TO 06:00 PM
Contact Info